0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Colorectal Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-36Z5698
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Colorectal Cancer Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Colorectal Cancer Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36Z5698
Report
October 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Colorectal Cancer Diagnostics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Colorectal Cancer Diagnostics - Market

Colorectal Cancer Diagnostics - Market

Colorectal cancer diagnostics are a wide range of screening tests and diagnosis procedures that are employed before treating a patient with colon cancer. A typical diagnosis of colorectal cancer consists of tests such as colonoscopy, biopsy, blood sample testing, CT scan, ultrasound, MRI and molecular testing of the growing tumor. 
The global market for Colorectal Cancer Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Colorectal Cancer Diagnostics by region & country, by Type, and by Application.
The Colorectal Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Diagnostics.
Market Segmentation

Scope of Colorectal Cancer Diagnostics - Market Report

Report Metric Details
Report Name Colorectal Cancer Diagnostics - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Hospitals
  • Specialty Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics, Exact Science Corporation, Pathway Genomics Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Colorectal Cancer Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Colorectal Cancer Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Colorectal Cancer Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Colorectal Cancer Diagnostics - Market report?

Ans: The main players in the Colorectal Cancer Diagnostics - Market are Biocept, Cancer Genetics, Foundation Medicine, Sysmex Corporation, Danaher Corporation, Epigenomics, Illumina, Rosetta Genomics, Exact Science Corporation, Pathway Genomics Corporation

What are the Application segmentation covered in the Colorectal Cancer Diagnostics - Market report?

Ans: The Applications covered in the Colorectal Cancer Diagnostics - Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Colorectal Cancer Diagnostics - Market report?

Ans: The Types covered in the Colorectal Cancer Diagnostics - Market report are FOB Tests, CTC Tests, CEA Tests, Others

Recommended Reports

Colorectal Diagnostics

General Cancer Diagnostics

Cancer Molecular Testing

1 Market Overview
1.1 Colorectal Cancer Diagnostics Product Introduction
1.2 Global Colorectal Cancer Diagnostics Market Size Forecast
1.3 Colorectal Cancer Diagnostics Market Trends & Drivers
1.3.1 Colorectal Cancer Diagnostics Industry Trends
1.3.2 Colorectal Cancer Diagnostics Market Drivers & Opportunity
1.3.3 Colorectal Cancer Diagnostics Market Challenges
1.3.4 Colorectal Cancer Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Colorectal Cancer Diagnostics Players Revenue Ranking (2023)
2.2 Global Colorectal Cancer Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Colorectal Cancer Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Colorectal Cancer Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Colorectal Cancer Diagnostics
2.6 Colorectal Cancer Diagnostics Market Competitive Analysis
2.6.1 Colorectal Cancer Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Colorectal Cancer Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 FOB Tests
3.1.2 CTC Tests
3.1.3 CEA Tests
3.1.4 Others
3.2 Global Colorectal Cancer Diagnostics Sales Value by Type
3.2.1 Global Colorectal Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Colorectal Cancer Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Colorectal Cancer Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Others
4.2 Global Colorectal Cancer Diagnostics Sales Value by Application
4.2.1 Global Colorectal Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Colorectal Cancer Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Colorectal Cancer Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Colorectal Cancer Diagnostics Sales Value by Region
5.1.1 Global Colorectal Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Colorectal Cancer Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Colorectal Cancer Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Colorectal Cancer Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Colorectal Cancer Diagnostics Sales Value, 2019-2030
5.2.2 North America Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Colorectal Cancer Diagnostics Sales Value, 2019-2030
5.3.2 Europe Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Colorectal Cancer Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Colorectal Cancer Diagnostics Sales Value, 2019-2030
5.5.2 South America Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Colorectal Cancer Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Colorectal Cancer Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Colorectal Cancer Diagnostics Sales Value
6.3 United States
6.3.1 United States Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.3.2 United States Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.4.2 Europe Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.5.2 China Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.6.2 Japan Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Colorectal Cancer Diagnostics Sales Value, 2019-2030
6.9.2 India Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Colorectal Cancer Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Profile
7.1.2 Biocept Main Business
7.1.3 Biocept Colorectal Cancer Diagnostics Products, Services and Solutions
7.1.4 Biocept Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Biocept Recent Developments
7.2 Cancer Genetics
7.2.1 Cancer Genetics Profile
7.2.2 Cancer Genetics Main Business
7.2.3 Cancer Genetics Colorectal Cancer Diagnostics Products, Services and Solutions
7.2.4 Cancer Genetics Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 Cancer Genetics Recent Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Profile
7.3.2 Foundation Medicine Main Business
7.3.3 Foundation Medicine Colorectal Cancer Diagnostics Products, Services and Solutions
7.3.4 Foundation Medicine Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Sysmex Corporation Recent Developments
7.4 Sysmex Corporation
7.4.1 Sysmex Corporation Profile
7.4.2 Sysmex Corporation Main Business
7.4.3 Sysmex Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
7.4.4 Sysmex Corporation Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Sysmex Corporation Recent Developments
7.5 Danaher Corporation
7.5.1 Danaher Corporation Profile
7.5.2 Danaher Corporation Main Business
7.5.3 Danaher Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
7.5.4 Danaher Corporation Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Danaher Corporation Recent Developments
7.6 Epigenomics
7.6.1 Epigenomics Profile
7.6.2 Epigenomics Main Business
7.6.3 Epigenomics Colorectal Cancer Diagnostics Products, Services and Solutions
7.6.4 Epigenomics Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Epigenomics Recent Developments
7.7 Illumina
7.7.1 Illumina Profile
7.7.2 Illumina Main Business
7.7.3 Illumina Colorectal Cancer Diagnostics Products, Services and Solutions
7.7.4 Illumina Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 Illumina Recent Developments
7.8 Rosetta Genomics
7.8.1 Rosetta Genomics Profile
7.8.2 Rosetta Genomics Main Business
7.8.3 Rosetta Genomics Colorectal Cancer Diagnostics Products, Services and Solutions
7.8.4 Rosetta Genomics Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 Rosetta Genomics Recent Developments
7.9 Exact Science Corporation
7.9.1 Exact Science Corporation Profile
7.9.2 Exact Science Corporation Main Business
7.9.3 Exact Science Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
7.9.4 Exact Science Corporation Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Exact Science Corporation Recent Developments
7.10 Pathway Genomics Corporation
7.10.1 Pathway Genomics Corporation Profile
7.10.2 Pathway Genomics Corporation Main Business
7.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
7.10.4 Pathway Genomics Corporation Colorectal Cancer Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Pathway Genomics Corporation Recent Developments
8 Industry Chain Analysis
8.1 Colorectal Cancer Diagnostics Industrial Chain
8.2 Colorectal Cancer Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Colorectal Cancer Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Colorectal Cancer Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Colorectal Cancer Diagnostics Market Trends
    Table 2. Colorectal Cancer Diagnostics Market Drivers & Opportunity
    Table 3. Colorectal Cancer Diagnostics Market Challenges
    Table 4. Colorectal Cancer Diagnostics Market Restraints
    Table 5. Global Colorectal Cancer Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Colorectal Cancer Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Colorectal Cancer Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Colorectal Cancer Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Colorectal Cancer Diagnostics
    Table 10. Global Colorectal Cancer Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Colorectal Cancer Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Colorectal Cancer Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Colorectal Cancer Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Colorectal Cancer Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Colorectal Cancer Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Colorectal Cancer Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Colorectal Cancer Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Colorectal Cancer Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Colorectal Cancer Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Colorectal Cancer Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Colorectal Cancer Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Colorectal Cancer Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Colorectal Cancer Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Colorectal Cancer Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Colorectal Cancer Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Colorectal Cancer Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Colorectal Cancer Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Colorectal Cancer Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Biocept Basic Information List
    Table 32. Biocept Description and Business Overview
    Table 33. Biocept Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Biocept (2019-2024)
    Table 35. Biocept Recent Developments
    Table 36. Cancer Genetics Basic Information List
    Table 37. Cancer Genetics Description and Business Overview
    Table 38. Cancer Genetics Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Cancer Genetics (2019-2024)
    Table 40. Cancer Genetics Recent Developments
    Table 41. Foundation Medicine Basic Information List
    Table 42. Foundation Medicine Description and Business Overview
    Table 43. Foundation Medicine Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Foundation Medicine (2019-2024)
    Table 45. Foundation Medicine Recent Developments
    Table 46. Sysmex Corporation Basic Information List
    Table 47. Sysmex Corporation Description and Business Overview
    Table 48. Sysmex Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Sysmex Corporation (2019-2024)
    Table 50. Sysmex Corporation Recent Developments
    Table 51. Danaher Corporation Basic Information List
    Table 52. Danaher Corporation Description and Business Overview
    Table 53. Danaher Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Danaher Corporation (2019-2024)
    Table 55. Danaher Corporation Recent Developments
    Table 56. Epigenomics Basic Information List
    Table 57. Epigenomics Description and Business Overview
    Table 58. Epigenomics Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Epigenomics (2019-2024)
    Table 60. Epigenomics Recent Developments
    Table 61. Illumina Basic Information List
    Table 62. Illumina Description and Business Overview
    Table 63. Illumina Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Illumina (2019-2024)
    Table 65. Illumina Recent Developments
    Table 66. Rosetta Genomics Basic Information List
    Table 67. Rosetta Genomics Description and Business Overview
    Table 68. Rosetta Genomics Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Rosetta Genomics (2019-2024)
    Table 70. Rosetta Genomics Recent Developments
    Table 71. Exact Science Corporation Basic Information List
    Table 72. Exact Science Corporation Description and Business Overview
    Table 73. Exact Science Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Exact Science Corporation (2019-2024)
    Table 75. Exact Science Corporation Recent Developments
    Table 76. Pathway Genomics Corporation Basic Information List
    Table 77. Pathway Genomics Corporation Description and Business Overview
    Table 78. Pathway Genomics Corporation Colorectal Cancer Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Colorectal Cancer Diagnostics Business of Pathway Genomics Corporation (2019-2024)
    Table 80. Pathway Genomics Corporation Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Colorectal Cancer Diagnostics Downstream Customers
    Table 84. Colorectal Cancer Diagnostics Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Colorectal Cancer Diagnostics Product Picture
    Figure 2. Global Colorectal Cancer Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Colorectal Cancer Diagnostics Report Years Considered
    Figure 5. Global Colorectal Cancer Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Colorectal Cancer Diagnostics Revenue in 2023
    Figure 7. Colorectal Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. FOB Tests Picture
    Figure 9. CTC Tests Picture
    Figure 10. CEA Tests Picture
    Figure 11. Others Picture
    Figure 12. Global Colorectal Cancer Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Colorectal Cancer Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Specialty Clinics
    Figure 16. Product Picture of Others
    Figure 17. Global Colorectal Cancer Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Colorectal Cancer Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Colorectal Cancer Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Colorectal Cancer Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Colorectal Cancer Diagnostics Sales Value (%), (2019-2030)
    Figure 30. United States Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Colorectal Cancer Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Colorectal Cancer Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Colorectal Cancer Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 51. Colorectal Cancer Diagnostics Industrial Chain
    Figure 52. Colorectal Cancer Diagnostics Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS